Subscribe
Today
Financial
Technology
Cyclical
Defensive
Healthcare
Energy
Industrials
Real Estate
Materials
Viewpoints
All Access Articles |
STOK
Stoke Therapeutics – FDA Breakthrough for Dravet Syndrome Treatment
| 2024-12-07 |
PHARMACEUTICAL
Stoke Therapeutics Prices Public Offering at $13.50 Per Share
| 2024-03-29 |
PHARMACEUTICAL
